Formula: | C25H29FN2O4 |
Molecular Weight: | 440.52 |
Rotatable Bond Donors: | 6 |
clogP: | 3.57 |
Topological Polar Surface Area: | 59.08 |
Lipinski's RO5: | MW: 440.52 HBA: 6 HBD: 0 RB: 6 LogP: 3.57 |
Rule of Three: | MW: 440.52 HBA: 6 HBD: 0 RB: 6 LogP: 3.57 |
|
ECBD ID | Similarity | Structure | SDF |
---|
ECBD ID | Similarity | Structure | SDF | |
---|---|---|---|---|
EOS16545 | 0.77 | EOS16545 RDKit 3D 27 30 0 0 0 0 0 0 0 0999 V2000 2.1932 -2.2170 -2.2610 O 0 0 0 0 0 0 0 0 0 0 0 0 2.0333 -1.8563 -1.0967 C 0 0 0 0 0 0 0 0 0 0 0 0 2.6799 -2.5858 0.0586 C 0 0 0 0 0 0 0 0 0 0 0 0 4.0611 -2.1049 0.3178 C 0 0 0 0 0 0 0 0 0 0 0 0 4.4186 -1.1398 1.3023 C 0 0 0 0 0 0 0 0 0 0 0 0 5.7659 -0.8937 1.3279 C 0 0 0 0 0 0 0 0 0 0 0 0 6.6245 -1.8148 0.1908 S 0 0 0 0 0 0 0 0 0 0 0 0 5.1873 -2.5451 -0.3365 C 0 0 0 0 0 0 0 0 0 0 0 0 1.2460 -0.7762 -0.7510 N 0 0 0 0 0 0 0 0 0 0 0 0 0.5985 -0.0408 -1.8137 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.5413 0.8118 -1.3009 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.1119 1.7388 -0.1744 C 0 0 0 0 0 0 0 0 0 0 0 0 0.4134 3.0324 -0.7815 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.7898 3.9662 -0.8558 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.7034 3.4426 0.2170 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.6679 4.0324 0.6723 O 0 0 0 0 0 0 0 0 0 0 0 0 -1.2516 2.1939 0.5886 N 0 0 0 0 0 0 0 0 0 0 0 0 -1.9398 1.3956 1.5765 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.8929 0.4115 0.9826 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.1407 0.8276 0.5136 C 0 0 0 0 0 0 0 0 0 0 0 0 -5.0306 -0.0964 -0.0269 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.6664 -1.4371 -0.0861 C 0 0 0 0 0 0 0 0 0 0 0 0 -5.5195 -2.3298 -0.6065 F 0 0 0 0 0 0 0 0 0 0 0 0 -3.4321 -1.8687 0.3879 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.5469 -0.9399 0.9277 C 0 0 0 0 0 0 0 0 0 0 0 0 0.9654 1.1504 0.7188 C 0 0 0 0 0 0 0 0 0 0 0 0 1.0476 -0.3566 0.6188 C 0 0 0 0 0 0 0 0 0 0 0 0 1 2 2 0 2 3 1 0 3 4 1 0 4 5 1 0 5 6 2 0 6 7 1 0 7 8 1 0 2 9 1 0 9 10 1 0 10 11 1 0 11 12 1 0 12 13 1 0 13 14 1 0 14 15 1 0 15 16 2 0 15 17 1 0 17 18 1 0 18 19 1 0 19 20 2 0 20 21 1 0 21 22 2 0 22 23 1 0 22 24 1 0 24 25 2 0 12 26 1 0 26 27 1 0 8 4 2 0 27 9 1 0 17 12 1 0 25 19 1 0 M END $$$$ |
Name | Assay stage | Target | Activity |
---|---|---|---|
GPR35 antagonism | primary assay | G-protein coupled receptor 35 | inactive |